Literature DB >> 12719630

Cdk5: one of the links between senile plaques and neurofibrillary tangles?

Ming-Sum Lee1, Li-Huei Tsai.   

Abstract

The relationship between amyloid plaques and neurofibrillary tangles, the two pathologic hallmarks of Alzheimer's disease (AD), is an unknown and controversial subject. However, emerging evidence from genetic and biochemical studies suggests that accumulation of amyloid beta peptides may play a causative role in AD pathogenesis. This led to the amyloid hypothesis, which proposes that amyloid beta peptides disrupt neuronal metabolic and ionic homeostasis and cause aberrant activation of kinases and/or inhibition of phosphatases. The resulting alteration in kinase and phosphatase activities ultimately leads to hyperphosphorylation of tau and formation of neurofibrillary tangles. Cyclin-dependent kinase 5 (Cdk5) is a tau kinase whose activity is induced by amyloid beta peptides. Its deregulation may represent one of the signal transduction pathways that connect amyloid beta toxicity to tau hyperphosphorylation. This article reviews the functions and regulation of Cdk5. Evidence that suggests deregulation of Cdk5 activity in AD by virtue of calpain cleavage of its activator p35 to p25 will be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12719630     DOI: 10.3233/jad-2003-5207

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  42 in total

1.  CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation.

Authors:  Jun-Ping Bai; Alexei Surguchev; Powrnima Joshi; Liza Gross; Dhasakumar Navaratnam
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-16       Impact factor: 4.249

2.  MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.

Authors:  Sabrina Absalon; Dawn M Kochanek; Venkatesan Raghavan; Anna M Krichevsky
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

3.  S-nitrosoglutathione reduces tau hyper-phosphorylation and provides neuroprotection in rat model of chronic cerebral hypoperfusion.

Authors:  Je-Seong Won; Balasubramaniam Annamalai; Seungho Choi; Inderjit Singh; Avtar K Singh
Journal:  Brain Res       Date:  2015-08-10       Impact factor: 3.252

4.  Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons.

Authors:  Ester Verdaguer; Daniel Alvira; Andrés Jiménez; Victor Rimbau; Antoni Camins; Mercè Pallàs
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

5.  A novel calcium-binding protein is associated with tau proteins in tauopathy.

Authors:  Irving E Vega; Edwin E Traverso; Yancy Ferrer-Acosta; Eduardo Matos; Migdalisel Colon; John Gonzalez; Dennis Dickson; Michael Hutton; Jada Lewis; Shu H Yen
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

6.  Differential expression and redox proteomics analyses of an Alzheimer disease transgenic mouse model: effects of the amyloid-β peptide of amyloid precursor protein.

Authors:  R A S Robinson; M B Lange; R Sultana; V Galvan; J Fombonne; O Gorostiza; J Zhang; G Warrier; J Cai; W M Pierce; D E Bredesen; D A Butterfield
Journal:  Neuroscience       Date:  2011-01-09       Impact factor: 3.590

7.  5-Lipoxygenase gene transfer worsens memory, amyloid, and tau brain pathologies in a mouse model of Alzheimer disease.

Authors:  Jin Chu; Phillip F Giannopoulos; Carolina Ceballos-Diaz; Todd E Golde; Domenico Praticò
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

8.  Cyclin-dependent kinase inhibitors attenuate protein hyperphosphorylation, cytoskeletal lesion formation, and motor defects in Niemann-Pick Type C mice.

Authors:  Min Zhang; Jin Li; Paramita Chakrabarty; Bitao Bu; Inez Vincent
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

9.  Developmental regulation of tau phosphorylation, tau kinases, and tau phosphatases.

Authors:  Yang Yu; Xiaoqin Run; Zhihou Liang; Yi Li; Fei Liu; Ying Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  J Neurochem       Date:  2009-01-13       Impact factor: 5.372

10.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.